The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland

Table 3

The biomarkers serum concentrations in the psoriatic patients with and without arthritis.

Biomarker	Psoriasis without arthritis	Psoriatic Arthritis	Logistic regression analysis (psoriatic; arthritis versus psoriasis without arthritis)
	M ± SD	M ± SD	OR (95% CI)
sRANKL (pmol/L)	85.242 ± 71.819	110.947 ± 77.652	1.005 (0.997, 1.012)	0.221
COMP (ng/mL)	646.779 ± 343.413	495.638 ± 314.577	0.999 (0.997, 1.000)	0.145
Osteoprotegerin (pmol/L)	3.684 ± 1.380	3.678 ± 1.088	0.996 (0.649, 1.528)	0.986
Osteoprotegerin/sRANKL	19.421 ± 25.687	6.177 ± 4.897	0.920 (0.843, 0.998)	0.049
IL-20 (pg/mL)	25.928 ± 19.222	20.746 ± 15.388	0.982 (0.948, 1.016)	0.297